Author

Zelalem Addis Mekonnen

Observed names: Mekonnen, Zelalem A., Z. A. Mekonnen, Zelalem A. Mekonnen, Zelalem Mekonnen

Institutions: Basil Hetzel Institute, The University of Adelaide

Observed institutions: Médecins Sans Frontières, Basil Hetzel Institute, Médecins Sans Frontières, Médecins Sans Frontières, Médecins Sans Frontières, The University of Adelaide

ORCID: 0000-0002-3705-4526

Observed ORCID: 0000-0002-3705-4526

OpenAlex ID: A5075124681

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

2022 · Feargal J. Ryan, Christopher M. Hope, et al. · BMC Medicine · 290

PDF

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice

2019 · B. Grubor-Bauk, D. K. Wijesundara, et al. · Science Advances · 81

PDF

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

2022 · Pablo Garcia-Valtanen, Christopher M. Hope, et al. · Cell Reports Medicine · 43

PDF

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study

2017 · Charles Abongomera, Ermias Diro, et al. · Clinical Infectious Diseases · 41

PDF

Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus

2019 · Zelalem A. Mekonnen, Branka Grubor-Bauk, et al. · Journal of Virology · 21

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines

2019 · Ashish C. Shrestha, Danushka K. Wijesundara, et al. · Vaccines · 15

PDF

Mechanistic Target of Rapamycin Inhibitors and Vaccine Response in Kidney Transplant Recipients

2025 · Griffith B. Perkins, Matthew J. Tunbridge, et al. · Journal of the American Society of Nephrology · 14

Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine

2023 · Danushka K. Wijesundara, Arthur Yeow, et al. · Molecular Therapy — Nucleic Acids · 13

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection

2019 · Zelalem A. Mekonnen, Branka Grubor-Bauk, et al. · Frontiers in Cellular and Infection Microbiology · 13

PDF

Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus

2020 · Jason Gummow, Makutiro G. Masavuli, et al. · Vaccines · 12

PDF

Screening lipid nanoparticles using DNA barcoding and qPCR

2025 · Dawei Liu, Xing Wang, et al. · Colloids and Surfaces B Biointerfaces · 11

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3

2020 · Zelalem A. Mekonnen, Makutiro G. Masavuli, et al. · Frontiers in Microbiology · 10

PDF

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia

2017 · Charles Abongomera, Koert Ritmeijer, et al. · PLoS ONE · 9

PDF

Schistosomiasis mansoni focus in Mekele City, northern Ethiopia.

2012 · Zelalem Mekonnen, Haftay Haileselassie, et al. · PubMed · 8

Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines

2025 · Pablo Garcia-Valtanen, Arthur E.L. Yeow, et al. · Molecular Therapy — Nucleic Acids · 6

Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression

2025 · Mahboubeh Hosseini-Kharat, Anthony Wignall, et al. · Pharmaceutics · 5

PDF

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19

2021 · Pablo Garcia Valtanen, Christopher M. Hope, et al. · SSRN Electronic Journal · 2

Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus

2026 · Ryan Santos, Zelalem A. Mekonnen, et al. · npj Vaccines · 1

PDF

Additional file 14 of Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection